Gene · 1874
Papers2,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of lncRNA and mRNA regulatory networks associated with gastric cancer progression. | Front Oncol | 2023 | 36969001 | PubTator, text mining | PubMed |
| Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies. | Cancer Res Treat | 2023 | 36960624 | PubTator, text mining | PubMed |
| The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities. | Nat Struct Mol Biol | 2023 | 36959262 | PubTator, text mining | PubMed |
| Evidence for the role of transcription factors in the co-transcriptional regulation of intron retention. | Genome Biol | 2023 | 36949544 | PubTator, text mining | PubMed |
| DAPL1 deficiency in mice impairs antioxidant defenses in the RPE and leads to retinal degeneration with AMD-like features. | Redox Biol | 2023 | 36933392 | PubTator, text mining | PubMed |
| GEMC1 and MCIDAS interactions with SWI/SNF complexes regulate the multiciliated cell-specific transcriptional program. | Cell Death Dis | 2023 | 36932059 | PubTator, text mining | PubMed |
| Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools. | Medicine (Baltimore) | 2023 | 36930083 | PubTator, text mining | PubMed |
| MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients. | NPJ Parkinsons Dis | 2023 | 36927756 | PubTator, text mining | PubMed |
| Role of E2F transcription factor in oral cancer: Recent insight and advancements. | Semin Cancer Biol | 2023 | 36924812 | PubTator, text mining | PubMed |
| Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest. | Fac Rev | 2023 | 36923701 | PubTator, text mining | PubMed |
| Elevated Levels of Lamin A Promote HR and NHEJ-Mediated Repair Mechanisms in High-Grade Ovarian Serous Carcinoma Cell Line. | Cells | 2023 | 36899893 | PubTator, text mining | PubMed |
| The TIMELESS effort for timely DNA replication and protection. | Cell Mol Life Sci | 2023 | 36892674 | PubTator, text mining | PubMed |
| p53 mutation and deletion contribute to tumor immune evasion. | Front Genet | 2023 | 36891151 | PubTator, text mining | PubMed |
| The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells. | mSphere | 2023 | 36883841 | PubTator, text mining | PubMed |
| Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma. | BMC Med Genomics | 2023 | 36855110 | PubTator, text mining | PubMed |
| The landscape of human p53-regulated long non-coding RNAs reveals critical host gene co-regulation. | Mol Oncol | 2023 | 36852646 | PubTator, text mining | PubMed |
| An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. | Cancer Sci | 2023 | 36840413 | PubTator, text mining | PubMed |
| Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity. | Medicina (Kaunas) | 2023 | 36837510 | PubTator, text mining | PubMed |
| Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse. | Int J Mol Sci | 2023 | 36835173 | PubTator, text mining | PubMed |
| Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. | Genes (Basel) | 2023 | 36833320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1874/papers?page=12